Exercise Dose and Metformin for Vascular Health in Adults with Metabolic Syndrome

Project Details

Description

PROJECT NARRATIVE/RELEVANCE Arterial vascular disease (including large to small peripheral vessels) is the major cause of morbidity and mortality in Metabolic Syndrome (MetS). We propose the first examination of pharmacology interaction with exercise training dose on improving baseline and insulin dependent vascular stiffness and function in middle- aged MetS patients. The proposed studies will define the role of pharmacology on optimal physical activity behavior to reverse clinical vascular and metabolic abnormalities as well as be the first effort to improve public health recommendations of physical activity when people are prescribed medication.
StatusFinished
Effective start/end date2/1/171/31/23

Funding

  • National Heart, Lung, and Blood Institute: $739,674.00
  • National Heart, Lung, and Blood Institute: $739,674.00
  • National Heart, Lung, and Blood Institute: $739,674.00
  • National Heart, Lung, and Blood Institute: $739,674.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.